X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
oncology (27) 27
humans (21) 21
animals (18) 18
female (18) 18
mice (18) 18
melanoma (15) 15
index medicus (13) 13
therapy (13) 13
cancer (10) 10
male (9) 9
tumor cells, cultured (9) 9
adult (8) 8
mice, inbred c57bl (8) 8
middle aged (8) 8
antineoplastic agents - therapeutic use (6) 6
cell line, tumor (6) 6
flow cytometry (6) 6
immunotherapy (6) 6
melanoma, experimental - metabolism (6) 6
original paper (6) 6
tumor necrosis factor-alpha - biosynthesis (6) 6
adamantane - analogs & derivatives (5) 5
adamantane - pharmacology (5) 5
aged (5) 5
antineoplastic agents - pharmacology (5) 5
diagnosis (5) 5
il-12 (5) 5
in-vivo (5) 5
mice, inbred balb c (5) 5
mice, inbred dba (5) 5
sarcoma (5) 5
tnf-α (5) 5
tumors (5) 5
analysis (4) 4
biochemistry & molecular biology (4) 4
cells (4) 4
disease models, animal (4) 4
disease-free survival (4) 4
interleukin-12 (4) 4
medicine, research & experimental (4) 4
metastasis (4) 4
metastatic melanoma (4) 4
photochemotherapy (4) 4
photodynamic therapy (4) 4
prognosis (4) 4
research (4) 4
time factors (4) 4
tnf-alpha (4) 4
treatment outcome (4) 4
vemurafenib (4) 4
young adult (4) 4
adamantane - chemical synthesis (3) 3
adolescent (3) 3
cancer research (3) 3
chemotherapy (3) 3
colon-cancer cells (3) 3
colony-stimulating factor (3) 3
cytotoxicity (3) 3
dendritic cells (3) 3
dermatology (3) 3
drug synergism (3) 3
drug therapy, combination (3) 3
efficacy (3) 3
enzyme-linked immunosorbent assay (3) 3
expression (3) 3
follow-up (3) 3
hematology (3) 3
hematology, oncology and palliative medicine (3) 3
imatinib mesylate (3) 3
immune response (3) 3
inhibition (3) 3
interleukin-12 - genetics (3) 3
internal medicine (3) 3
lung neoplasms - drug therapy (3) 3
medicine (3) 3
medicine & public health (3) 3
melanoma, experimental - genetics (3) 3
metastases (3) 3
necrosis-factor-alpha (3) 3
ovarian cancer (3) 3
pathology (3) 3
pharmacology & pharmacy (3) 3
proteins (3) 3
sunitinib (3) 3
survival (3) 3
tumor (3) 3
adamantane (2) 2
adamantane - chemistry (2) 2
adamantylation (2) 2
aged, 80 and over (2) 2
alveolar soft part sarcoma (2) 2
aminopyridines - pharmacology (2) 2
antineoplastic agents - administration & dosage (2) 2
antineoplastic combined chemotherapy protocols - therapeutic use (2) 2
apoptosis (2) 2
articles (2) 2
azacitidine - analogs & derivatives (2) 2
biological response modifiers (2) 2
biotechnology & applied microbiology (2) 2
bone neoplasms - pathology (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
BMC Cancer, ISSN 1471-2407, 03/2012, Volume 12, Issue 1, pp. 107 - 107
Journal Article
Nowotwory, ISSN 0029-540X, 11/2018, Volume 68, Issue 3, pp. 140 - 145
Journal Article
International Journal of Biochemistry and Cell Biology, ISSN 1357-2725, 08/2014, Volume 53, pp. 466 - 474
Journal Article
Clinical Cancer Research, ISSN 1078-0432, 07/2004, Volume 10, Issue 13, pp. 4498 - 4508
Journal Article
Journal Article
Wspolczesna Onkologia, ISSN 1428-2526, 2013, Volume 17, Issue 3, pp. 257 - 262
Aim of the study: The Patient Assistance Program, a type of expanded access program, was initiated for compassionate purposes to provide ipilimumab to patients... 
CTLA-4 | Immunotherapy | Ipilimumab | Outcome | Melanoma | CTLA-4 BLOCKADE | ONCOLOGY | TOLERABILITY | ipilimumab | immunotherapy | melanoma | ANTI-CTLA-4 ANTIBODIES | EXPERIENCE | DACARBAZINE | outcome | Original Paper
Journal Article
Journal Article
Dermatology Review, ISSN 0033-2526, 2016, Volume 1, Issue 1, pp. 1 - 18
  Dermoscopy is currently the standard method for clinical differential diagnosis of cutaneous melanoma and for qualifying a lesion for excisional biopsy. Full... 
cutaneous melanoma | diagnosis | therapy
Journal Article
WSPOLCZESNA ONKOLOGIA-CONTEMPORARY ONCOLOGY, ISSN 1428-2526, 2015, Volume 19, Issue 4, pp. 280 - 283
Aim of the study: The BRAF inhibitor vemurafenib has improved progression- free survival and overall survival in patients with BRAFV600-mutation-positive... 
vemurafenib | melanoma | metastatic | ONCOLOGY | BRAF inhibition | Original Paper
Journal Article
Clinical Cancer Research, ISSN 1078-0432, 08/2003, Volume 9, Issue 8, pp. 3124 - 3133
Journal Article
Wspolczesna Onkologia, ISSN 1428-2526, 2012, Volume 16, Issue 6, pp. 532 - 545
Aim of the study:The incidence of melanoma is increasing rapidly worldwide. Metastatic melanoma is still an incurable disease, although an era of new drugs is... 
Therapy | Outcomes | Prognostic factors | Melanoma | Metastases | SURVIVAL | INTERLEUKIN-2 | PROGNOSTIC-FACTORS | therapy | BIOCHEMOTHERAPY | melanoma | prognostic factors | DACARBAZINE | AMERICAN JOINT COMMITTEE | CHEMOTHERAPY | metastases | METASTATIC MALIGNANT-MELANOMA | CISPLATIN | ONCOLOGY | outcomes | RANDOMIZED PHASE-III | Original Paper
Journal Article
Nowotwory. Journal of Oncology, ISSN 0029-540X, 05/2014, Volume 64, Issue II, pp. 1 - 19
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.